- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 19, 2026 | 30.12M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 26.26M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 9.97M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $10.5M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$9.82M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$785K |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $127.78M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $127.36M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $0 |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $107K |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $2.69M |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $3.68M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $10.19M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $99.26M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $2.85M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $3.5M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $91.74M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $80.79M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $219.52M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $208.15M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $127.77M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $121.93M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $229.72M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $307.41M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.18 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.18 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $6.01M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $543K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $141K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $169K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$83.39M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$778K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$55.22M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$883K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $103K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $7K |
| Revenue | Q1 2026 · Mar 31, 2026 | $2.66M |
| Revenue | Q1 2026 · Mar 31, 2025 | $287K |